Concepedia

Katsuyuki Maki

KM

13

Publications

847

Citations

13

H-Index

1991

Active since

Affiliations

Astellas Pharma (Japan)(Current)

University of Otago

Mochida Pharmaceutical (Japan)

National Institute of Infectious Diseases

Toho University

Katsuyuki Maki is an author at Astellas Pharma (Japan) specializing in pharmacology, antifungal agents, and medicinal chemistry.

Top concepts

Publications per year

1991–2014

13

Publications

13

In Vitro Activities of a New Lipopeptide Antifungal Agent, FK463, against a Variety of Clinically Important Fungi

Shuichi Tawara, Fumiaki Ikeda, Katsuyuki Maki et al. · Antimicrobial Agents and Chemotherapy · 2000 · 310 citations

Efficacy of FK463, a New Lipopeptide Antifungal Agent, in Mouse Models of Disseminated Candidiasis and Aspergillosis

Fumiaki Ikeda, Yoshimi Wakai, Satoru Matsumoto et al. · Antimicrobial Agents and Chemotherapy · 2000 · 147 citations · Full text

Overexpression of<i>Candida albicans CDR1</i>,<i>CDR2</i>, or<i>MDR1</i>Does Not Produce Significant Changes in Echinocandin Susceptibility

Kyoko Niimi, Katsuyuki Maki, Fumiaki Ikeda et al. · Antimicrobial Agents and Chemotherapy · 2006 · 137 citations · Full text

Clinically significant micafungin resistance in Candida albicans involves modification of a glucan synthase catalytic subunit GSC1 (FKS1) allele followed by loss of heterozygosity

Kyoko Niimi, Brian C. Monk, Asuka Hirai et al. · Journal of Antimicrobial Chemotherapy · 2010 · 47 citations

FR290581, a novel sordarin derivative: Synthesis and antifungal activity

Tadaatsu Hanadate, Masaki Tomishima, Nobuyuki Shiraishi et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 36 citations

, , +2

Rows per page

1–5 of 13